Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Kedudukan dalam Saham #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcotโ€“Marieโ€“Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Harga Saham
$0.05124204
Modal Pasaran
$7.78M
Perubahan (1 hari)
0.51%
Perubahan (1 tahun)
-23.73%
Negara
CH
Perdagangan Addex Therapeutics Ltd (ADXN)

Kategori

Sejarah pecahan saham untuk Addex Therapeutics Ltd (ADXN)
Saham Addex Therapeutics Ltd (simbol: ADXN) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 17, 2026.
Satu saham ADXN yang dibeli sebelum Aug 17, 2026 kini bersamaan dengan 0 saham ADXN.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE